Latest Breaking News On - Pharma companies pull imbruvica indication - Page 1 : comparemela.com

A treatment combination that includes Velcade and Rituxan helps improve responses and the safety profile in marginal zone lymphoma, according to a phase 2 trial.

Junfeng chuLymphoma societyPharma companies pull imbruvica indicationMarginal zoneMantle cellLymphoma cancer